Literature DB >> 17142519

Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization.

Paolo Manzoni1, Daniele Farina, MariaLisa Leonessa, Elisa Antonielli d'Oulx, Paolo Galletto, Michael Mostert, Roberto Miniero, Giovanna Gomirato.   

Abstract

OBJECTIVE: Colonization by Candida spp is a major risk factor for development of fungal sepsis, but little is known about the variables associated with progression to invasive disease in already colonized neonates. We investigated such variables in a large number of colonized preterm neonates in an NICU.
SETTING: This study was conducted in the Department of Neonatology and the NICU at Sant'Anna Hospital in Torino, Italy. DESIGN AND PATIENTS: A database search of clinical charts and weekly surveillance cultures was used to identify all neonates with birth weights < 1500 g (very low birth weight) who were admitted to our NICU during 1998-2005 and were colonized (> or = 1 site) by Candida spp during their stay, as well as infants with invasive fungal infection. The association between a number of factors with progression to invasive fungal infection was evaluated. Those shown to be significantly associated by univariate analysis were cross-checked by logistic regression.
RESULTS: Colonization occurred in 201 infants (32.1% of very low birth weight admitted neonates), and invasive fungal infection occurred in 51 (8.1%) of them, with an overall progression rate of 0.25. At univariate analysis, 10 factors (namely low birth weight, low gestational age, use of third-generation cephalosporins, endotracheal intubation, duration of stay in the NICU, bacterial sepsis, colonization of central venous catheter, of endotracheal tube, of gastric aspirate, or in > or = 3 [multiple] sites) were associated with an increased risk of progression, whereas prophylaxis with fluconazole was associated to a decreased risk. After logistic regression, only colonization of central venous catheter and colonization in multiple sites remained significantly associated with invasive fungal infection. Fluconazole prophylaxis remained an independent protective factor.
CONCLUSIONS: Central venous catheter colonization and multiple-site colonization are independent risk factors and predictors of progression to fungal sepsis in preterm very low birth weight neonates colonized by Candida spp during their stay in the NICU. Fluconazole prophylaxis is an independent protective factor. These findings can be used to improve the surveillance, prophylaxis, or preemptive measures in neonates at high risk.

Entities:  

Mesh:

Year:  2006        PMID: 17142519     DOI: 10.1542/peds.2006-1311

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  24 in total

Review 1.  Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants.

Authors:  Nicola Austin; Jemma Cleminson; Brian A Darlow; William McGuire
Journal:  Cochrane Database Syst Rev       Date:  2015-10-24

2.  Prevalence and immediate outcome of candida colonized preterm neonates admitted to Special Care Unit of Mulago Hospital, Kampala Uganda.

Authors:  Yaser Abdallah; Deogratias Kaddu-Mulindwa; Jolly Nankunda; Philippa M Musoke
Journal:  Afr Health Sci       Date:  2015-03       Impact factor: 0.927

3.  The risk of catheter-related bloodstream infection after withdrawal of colonized catheters is low.

Authors:  M Guembe; M Rodríguez-Créixems; P Martín-Rabadán; L Alcalá; P Muñoz; E Bouza
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-31       Impact factor: 3.267

4.  Dietary Supplementation With Medium-Chain Triglycerides Reduces Candida Gastrointestinal Colonization in Preterm Infants.

Authors:  Amanda B Arsenault; Kearney T W Gunsalus; Sonia S Laforce-Nesbitt; Lynn Przystac; Erik J DeAngelis; Michaela E Hurley; Ethan S Vorel; Richard Tucker; Nirupa R Matthan; Alice H Lichtenstein; Carol A Kumamoto; Joseph M Bliss
Journal:  Pediatr Infect Dis J       Date:  2019-02       Impact factor: 2.129

5.  Candida virulence properties and adverse clinical outcomes in neonatal candidiasis.

Authors:  Joseph M Bliss; Angela Y Wong; Grace Bhak; Sonia S Laforce-Nesbitt; Sarah Taylor; Sylvia Tan; Barbara J Stoll; Rosemary D Higgins; Seetha Shankaran; Daniel K Benjamin
Journal:  J Pediatr       Date:  2012-04-14       Impact factor: 4.406

Review 6.  Triazole use in the nursery: fluconazole, voriconazole, posaconazole, and ravuconazole.

Authors:  Kevin Watt; Paolo Manzoni; Michael Cohen-Wolkowiez; Stefano Rizzollo; Elena Boano; Evelyne Jacqz-Aigrain; Daniel K Benjamin
Journal:  Curr Drug Metab       Date:  2013-02       Impact factor: 3.731

7.  Prophylactic Saccharomyces boulardii versus nystatin for the prevention of fungal colonization and invasive fungal infection in premature infants.

Authors:  Gamze Demirel; Istemi Han Celik; Omer Erdeve; Sibel Saygan; Ugur Dilmen; Fuat Emre Canpolat
Journal:  Eur J Pediatr       Date:  2013-05-24       Impact factor: 3.183

8.  Neonatal Candidiasis: New Insights into an Old Problem at a Unique Host-Pathogen Interface.

Authors:  Amanda B Arsenault; Joseph M Bliss
Journal:  Curr Fungal Infect Rep       Date:  2015-09-07

Review 9.  Clinical aspects of invasive candidiasis in paediatric patients.

Authors:  Elio Castagnola; Silvia Buratti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

10.  Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection.

Authors:  Brian A McCrossan; Elaine McHenry; Fiona O'Neill; Grace Ong; David G Sweet
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-04-25       Impact factor: 5.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.